Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma - Takeaways - MDSpire

Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma

  • By

  • Jia Feng

  • Yuankai Si

  • Long Han

  • Yilan Huang

  • Longyang Jiang

  • June 23, 2026

  • 0 min

Share

  • 1

    A prognostic model based on eight MMR-related genes was developed to predict survival in glioma patients.

  • 2

    The risk score from the model serves as an independent prognostic indicator, distinguishing high-risk patients with poorer survival.

  • 3

    MCM8 was identified as a potential target for enhancing sensitivity to temozolomide in glioma treatment.

  • 4

    The study utilized data from TCGA and CGGA to validate the model's efficacy through various statistical analyses.

  • 5

    Disparities in immune infiltration and tumor microenvironment were observed across different risk categories in glioma patients.

Original Source(s)

Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma

  • by Jia Feng, Yuankai Si, Long Han, Yilan Huang, Longyang Jiang

  • June 23, 2026

Related Content

Endovascular thrombectomy in selected patients with active cancer and thrombocytopenia: outcomes under an institutional platelet transfusion practice

Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Integrated therapy including acupuncture in a patient with long-term survival from spinal cord metastases of ALK-positive lung adenocarcinoma: a case report